Venture capital and other private financings of private biopharma companies, including: Adagene, Aegle, Agilvax, Airway, Alderaan, Aligos, Arpeggio, Biograil, Biointervene, Bionetix, Calidi, Cerebral, Codagenix, Domain, Empirico, Eqrx, Fusion, Genesen, Heparegenix, Idbydna, Immuneering, Jasper, Kyverna, Lyra, Nference, Northsea, Seekyo, Tarsus, Treadwell, Tscan, Tyra, Urania, Vectivbio.